Werewolf Therapeutics, Inc. financial statements
Werewolf Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 0 | EODHD |
| Net income | −USD 60.82M | 10-K |
| Cash and equivalents | USD 57.05M | 10-Q |
| Total debt | USD 32.09M | 10-K |
Werewolf Therapeutics, Inc. financials on 6ix · Werewolf Therapeutics, Inc. on 6ix